Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tim Brier"'
Autor:
Nicholas Turner, Christos Vaklavas, Emiliano Calvo, Javier Garcia-Corbacho, Jason Incorvati, Manuel Ruiz Borrego, Chris Twelves, Anne Armstrong, Begoña Bermejo, Erika Hamilton, Mafalda Oliveira, Eva Ciruelos, Peter Kabos, Manish R Patel, Maria Borrell, Howard Burris, Bruno de Paula, Alejandro Falcon, Cristina Hernando, Irene Moreno, Ciara S. O’Brien, Elena Shagisultanova, Ivan Victoria Ruiz, Judy S. Wang, Mei Wei, Tim Brier, Danielle Carroll, Carmela Ciardullo, Lisa Gibbons, itziar irurzun-Arana, Tony Jack, bistra kirova, Teresa Klinowska, Justin Lindemann, Julie Maidment, Alastair Mathewson, Rhiannon Maudsley, Robert McEwen, Christopher Morrow, Andy Sykes, Richard D. Baird
Background: SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in women with ER+/HER2− advanced breast cancer. Parts A/B and C/D (escalation/expansion) examined camizestrant as monotherapy and in combination with palb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3b0f1e0fcbdd82a029a528d47540d2
https://www.repository.cam.ac.uk/handle/1810/350214
https://www.repository.cam.ac.uk/handle/1810/350214
Autor:
Andy Sykes, Christopher J. Morrow, Richard D. Baird, Teresa Klinowska, Rhiannon Maudsley, Marta Capelán Rodríguez, Manuel Ruiz-Borrego, Tim Brier, Bistra Kirova, Justin P.O. Lindemann, Nitharsan Sathiyayogan, Christina Hernando, Julia Lai-Kwon, Javier Garcia-Corbacho, Judy S. Wang, Begoña Bermejo de las Heras, Steven Fox, Mafalda Oliveira, Chris Leach, Eva Maria Ciruelos Gil, Anne C Armstrong, Richard Mather, Erika Hamilton, Manish R. Patel, Jason Incorvati, Udai Banerji, Valentina Boni, Chris Twelves, Ivan Victoria Ruiz, Bruno de Paula, Alejandro González, Li Zhang, Anosheh Afghani, Peter Kabos, Christos Vaklavas, Adam L. Cohen
Publikováno v:
Cancer Research. 81:PS11-05
Background: AZD9833 is an oral selective estrogen receptor (ER) antagonist and degrader (SERD) in Phase 2 clinical development for the treatment of ER+ HER2− breast cancer. Here we report data from Parts C and D of the ongoing Phase 1 study (SERENA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72b8540deb1a95e3a1f45931a47ee6e
https://doi.org/10.1158/1538-7445.sabcs20-ps11-05
https://doi.org/10.1158/1538-7445.sabcs20-ps11-05
Autor:
Mafalda Oliveira, Erika P. Hamilton, Jason Incorvati, Begoña Bermejo de la Heras, Emiliano Calvo, Javier García-Corbacho, Manuel Ruiz-Borrego, Christos Vaklavas, Nicholas C. Turner, Eva M. Ciruelos, Manish R. Patel, Anne C. Armstrong, Peter Kabos, Chris Twelves, Tim Brier, Itziar Irurzun-Arana, Teresa Klinowska, Justin P.O. Lindemann, Christopher J. Morrow, Richard D. Baird
Publikováno v:
Journal of Clinical Oncology. 40:1032-1032
1032 Background: SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in women with ER+, HER2− advanced breast cancer (ABC). Parts A/B (escalation/expansion) assessed camizestrant monotherapy and have been presented pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d509b4cb0e0075fc8f6044d6d9065487
https://doi.org/10.1200/jco.2022.40.16_suppl.1032
https://doi.org/10.1200/jco.2022.40.16_suppl.1032
Autor:
Manish R. Patel, Erika Hamilton, Justin P.O. Lindemann, Richard Mather, Danielle Carroll, Tim Brier, Udai Banerji, Javier Garcia-Corbacho, Richard D. Baird, Steven Fox, Chris Twelves, Eva Ciruelos, Rhiannon Maudsley, Sam McGuinness, Teresa Klinowska, Jason Incorvati, Anne C Armstrong, Andy Sykes, Mafalda Oliveira, Cristina Hernando
Publikováno v:
Publons
1024 Background: AZD9833 is an oral selective estrogen receptor (ER) antagonist and degrader (SERD) that has shown antitumor efficacy in a range of preclinical models of breast cancer. Methods: SERENA-1 (NCT03616587) is an ongoing Phase 1, open-label
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f97a0194f70088f4eedf13e622939baf
https://publons.com/publon/45658332/
https://publons.com/publon/45658332/